Pluto pulls together medical records, insurance data and social factors from roughly 90 percent of U.S. health systems without asking patients to remember or upload anything. It uses AI to sift through a person’s full history—labs, medications, past diagnoses and social determinants—to flag missed screenings or preventive needs in minutes rather than days. That intelligence then drives next steps: scheduling at-home lab tests, vaccines or cancer screenings, even pre-screening for clinical trials. The platform plugs into existing workflows via white-label apps, turnkey services or APIs. Providers, payors and life-science partners get a single view instead of juggling separate tools for data aggregation, analytics and patient outreach. For patients who don’t like apps, Pluto offers phone-based workflows. Behind the scenes, it meets SOC2 Type II, ISO 27001 and FDA 21 CFR Part 11 standards. Health systems use Pluto to shrink readmissions and boost quality metrics by automating gap closure. Pharma teams tap its ontology-driven matching—using CPT, ICD and SNOMED codes—to find eligible trial participants and hit diversity goals. Public health agencies identify underserved neighborhoods, deliver at-home tests and vaccines, and track outcomes over time. By combining clinical support with continuous event monitoring, Pluto stitches together preventive care, research recruitment and community outreach in a single platform.